Haemonetics
HAE • NYSE
Haemonetics is a medical - instruments & supplies company in the healthcare sector trading on NYSE, led by CEO Christopher A. Simon, with a market cap of $2.7B.
Market Cap$2.7B
Employees3.7K
CEOChristopher A. Simon
CountryUnited States of America
Healthcare
Medical - Instruments & Supplies
Next EarningsMay 7, 2026 · In 3 weeksQ4 2026
Financials
Haemonetics FAQ
Common questions about Haemonetics
Haemonetics is scheduled to report earnings for Q4 2026 on May 7, 2026. Analysts estimate revenue of $337.5M.
Haemonetics has approximately 3,657 employees.